Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Interest Expenses (2020 - 2021)

BioAtla's Interest Expenses history spans 2 years, with the latest figure at $1000.0 for Q2 2021.

  • For Q2 2021, Interest Expenses fell 98.73% year-over-year to $1000.0; the TTM value through Mar 2022 reached $1000.0, down 99.93%, while the annual FY2021 figure was $3000.0, 99.78% down from the prior year.
  • Interest Expenses reached $1000.0 in Q2 2021 per BCAB's latest filing, down from $2000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.2 million in Q4 2020 to a low of $1000.0 in Q2 2021.